D
Jazz Pharmaceuticals plc JAZZ
$108.99 -$1.50-1.36%
Recommendation
Sell
Prev Close
$110.49
Volume
574,128
Avg Vol (90D)
626,566
Market Cap
$6.97B
Dividend & Yield
--
52-Week Range
$103.01 - $146.70
P/E (TTM)
22.80
EPS (TTM)
$4.85
My Lists My Alerts
Report
Rating
Reward
D+
Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Fair
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
3 Cheap Blue-Chip Stocks to Buy Now: May 2024
5/17/2024 - InvestorPlace
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
5/16/2024 - Zacks Investment Research
Jazz Pharmaceuticals Larger Than S&P 500 Component Invesco
5/13/2024 - The Online Investor
Johnson Investment Counsel Inc. Sells 700 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
5/13/2024 - Ticker Report
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells $548,250.00 in Stock
5/10/2024 - Ticker Report
7 Cannabis Stocks to Buy for a Smoking-Hot 2024
5/9/2024 - InvestorPlace
We Did The Math PILL Can Go To $10
5/9/2024 - ETF Channel
Neena M. Patil Sells 5,000 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock
5/9/2024 - Zolmax
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy?
5/8/2024 - InvestorPlace
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript
5/8/2024 - Insider Monkey
Ligand (LGND) Beats Q1 Earnings, Misses Sales Estimates
5/8/2024 - Zacks Investment Research
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
5/7/2024 - Zacks Investment Research
Jazz (JAZZ) International Revenue Performance Explored
5/6/2024 - Zacks Investment Research
Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target Cut to $200.00
5/5/2024 - Ticker Report
StockNews.com Downgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to Buy
5/5/2024 - Ticker Report
LSV Asset Management Has $288.22 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
5/5/2024 - Ticker Report
Los Angeles Capital Management LLC Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
5/4/2024 - Ticker Report
HC Wainwright Reaffirms Buy Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)
5/4/2024 - Ticker Report
Jazz Pharmaceuticals price target lowered by $30 at Barclays, here's why
5/3/2024 - The Fly
Analysts Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) PT at $195.08
5/3/2024 - Ticker Report
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
5/2/2024 - Zacks Investment Research
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews
5/2/2024 - Benzinga
Jazz Pharmaceuticals price target lowered by $25 at TD Cowen, here's why
5/2/2024 - The Fly
Q1 2024 Jazz Pharmaceuticals PLC Earnings Call Transcript
5/2/2024 - GuruFocus
JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
5/2/2024 - InvestorPlace
Income Statement
Total Revenue (TTM)
$3.84B
EBITDA (TTM)
$1.31B
EBIT (TTM)
$669.73M
Net Income (TTM)
$330.79M
Balance Sheet
Total Assets (Q)
$11.33B
Total Debt (Q)
$5.79B
Total Liabilities (Q)
$7.63B
Book Value Per Share (Q)
$58.65
Cash Flow
Cash from Operations (TTM)
$1.04B
Cash from Investing (TTM)
-$430.14M
Cash from Financing (TTM)
-$332.02M
Net Change in Cash (TTM)
$275.47M
Filings
Filing Date
Thursday, May 2, 2024
Period Date
Sunday, March 31, 2024
Next Filing
Week of Aug 5 and 9 (est)
Price History
Loading...
Beta
0.65
7-Day Total Return
2.19%
30-Day Total Return
-2.83%
60-Day Total Return
-11.93%
90-Day Total Return
-7.57%
Year to Date Total Return
-10.88%
1-Year Total Return
-14.41%
2-Year Total Return
-25.73%
3-Year Total Return
-36.02%
5-Year Total Return
-18.71%
52-week Low
May 02, 2024 - $103.01
52-week High
Aug 31, 2023 - $146.70
Valuation
Market Cap
$6.97B - Mid Cap
Enterprise Value
$10.93B
Price/Sales (TTM)
1.80
Price/Book (Q)
1.88
Dividends and Shares
Shares Outstanding
62.54M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.jazzpharma.com
Phone Number
353 1 634 7800
Address
Waterloo Exchange
Fifth Floor - Waterloo Road
Dublin, D04 E5W7
Country
Ireland
Year Founded
2003
Business Description
Sector
--
Industry
--
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products for unmet medical needs in the United States, Europe, and internationally. The company offers Xywav for... more
NASDAQ 05/17/2024 4:00PM Eastern Quotes delayed
Weiss Ratings